🇺🇸 FDA
Patent

US 11723923

Methods of preparing T cells for T cell therapy

granted A61KA61K2039/572A61K40/11

Quick answer

US patent 11723923 (Methods of preparing T cells for T cell therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/572, A61K40/11, A61K40/32, A61K40/4268